BSX

NYSE

BOSTON SCIENTIFIC CORP

Health Care, Health Care Equipment

$49.31

close 7 Aug 2026

-52.01%

52-week change

$71.46B

market cap

$42.20

$109.50

52-week range

Valuation

Market cap$71.46B

P/E (TTM / 5y avg)19.96x70.61x

Forward P/E (FY2026 / FY2027)14.93x14.34x

PEG (TTM / fwd)0.323.66

P/S (TTM)3.40x

P/B2.87x

EV/EBITDA (TTM)14.74x

FCF yield (TTM)5.07%

Cash flow & dividend

FCF (TTM)$3.63B

FCF per share (TTM)$2.50

FCF margin (TTM)17.27%

Dividend yield (indicated / 5y avg)——

Annualized dividend—

Payout ratio (EPS / FCF)——

Growth & quality

Revenue YoY, latest Q+7.53%

Diluted EPS YoY, latest Q+15.09%

Operating margin (TTM)19.78%

Net margin (TTM)17.48%

ROE (latest FY)11.93%

Net debt / EBITDA (TTM)2.13

Interest coverage (TTM)11.44

Price

+11.23%+2.16%/yrover 5y

Weekly closes · split-adjusted

close 7 Aug 2026

Fundamentals

Fiscal years, last 10, CAGR chips on growth series, plus a dimmed trailing-twelve-month bar

Revenue

5Y CAGR +15.16%10Y CAGR +10.38%

Diluted EPS

FCF per share

5Y CAGR +17.31%10Y CAGR +22.06%

Operating cash flow

5Y CAGR +24.63%10Y CAGR +20.70%

Free cash flow

5Y CAGR +26.44%10Y CAGR +23.48%

Dividends per share

Payout ratio

FCF payout ratio

Operating margin

FCF margin

Return on equity

Return on capital employed

Shares outstanding

5Y CAGR +7.78%10Y CAGR +1.02%

Net debt / EBITDA

Interest coverage

Earnings

Street estimates, not SEC filings

Next / Q3 FY26

Date20 Oct 2026bmo

EPS estimate$0.8133

Revenue estimate$5.31B

Last reported

Date—

EPS——

Revenue——